Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AusCann
Perth, Western Australia, Australia
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
AusCann was the first company in Australia to receive a license to grow and export medicinal cannabis, commercialized dose-controlled cannabinoid medicines; partnered in 2025 to accelerate pharmaceutical cannabinoid development
- Therapeutic areas
- NeurologyOther
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Partnerships
Tasmanian Alkaloids (manufacturing/production partner)Argent Biopharma (2025 agreement on cannabinoid development)Canopy Growth (historical, stake sold 2019)
Beyond the preview
Go deeper on AusCann.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AusCann.